Jakafi is a kinase inhibitor indicated for treatment of:
• intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera
myelofibrosis and post-essential thrombocythemia myelofibrosis in adults.
• polycythemia vera in adults who have had an inadequate response to or are intolerant of
hydroxyurea.
• steroid-refractory acute graft-versus-host disease in adult and pediatric patients 12 years and
older.
Brand Name "JAKAFI (ruxolitinib) tablets" medication can be imported and made available on "Named Patient Program (NPP)" treatment in Philippines, Vietnam, Ireland and India. Please contact at +91 9910645395 (Mr. Rakesh) or make an enquiry at info@cancermedicinesnetwork to find the cost price to buy "JAKAFI (ruxolitinib) tablets" online and have it delivered where you live. We take guarantee of quality and delivery as per the buyer’s requirements.
Patient, Physcian, distributor/supplier can buy and import Brand Name "JAKAFI (ruxolitinib) tablets" from Verve Biosciences, if the drug has not been approved or is not available in your country. Make an enquiry and we will help you calculate the total price to buy "JAKAFI (ruxolitinib) tablets" online and have it delivered where you live. From your side, we’ll simply need a prescription from your treating doctor. In some countries we might also need an import license. Our Patient Support team will guide you throughout the process.
Verve Biosciences facilitates import of anti-cancer medicines JAKAFI (ruxolitinib) tablets, Make an enquiry to find the total cost of JAKAFI (ruxolitinib) tablets in UAE, Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.